A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors
发布时间：2021-09-23 点击数：
所属单位：山东大学齐鲁医院
论文名称：A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors
发表刊物：Frontiers in Immunology
第一作者：李松
论文编号：AB70ECD038A944308B2991A448E8AA1E
卷号：12
字数：6
是否译文：否
发表时间：2021-06
上一条： What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis
下一条： Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis